Rockwell Medical, Inc. (RMTI) vs SCYNEXIS, Inc. (SCYX)

Rockwell Medical, Inc. and SCYNEXIS, Inc. are both Drug Manufacturers Specialty & Generic companies. Rockwell Medical, Inc. and SCYNEXIS, Inc. are of similar size ($32.8M and $30.6M). SCYNEXIS, Inc. grew revenue faster over the last twelve months: 682.5% against −21.1%. Rockwell Medical, Inc. has the higher net margin (−7.33% vs −49.7%) and the higher return on invested capital (−14.6% vs −110.7%). Across the 18 metrics below, Rockwell Medical, Inc. leads on 10 and SCYNEXIS, Inc. on 8.

Valuation

Metric RMTI SCYX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.44 1.91 2.08
P/B 0.87 0.59 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.21 0.54 2.87
Earnings yield (17.40%) (62.76%) (15.94%)
Free cash flow yield (3.22%) (33.85%) 0.00%

Profitability

Metric RMTI SCYX Drug Manufacturers Specialty & Generic median
Gross margin 17.71% 100.00% 53.51%
Operating margin (6.52%) (109.90%) 0.00%
Net margin (7.33%) (49.74%) (2.45%)
Free cash flow margin 2.47% (64.67%) 0.00%
Return on equity (15.53%) (18.38%) (0.80%)
Return on assets (9.32%) (15.09%) (1.67%)
Return on invested capital (14.58%) (110.72%) 0.00%

Growth

Metric RMTI SCYX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (21.12%) 682.47% 5.22%
EPS growth (last fiscal year) (870.87%) 61.36% 42.91%
Revenue growth, 5-year CAGR 2.17% 179.40% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RMTI SCYX Drug Manufacturers Specialty & Generic median
Debt to equity 0.26 0.00 0.04
Current ratio 3.25 9.65 2.41
Net debt to EBITDA 7.40 2.54 1.01

Dividend

Metric RMTI SCYX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric RMTI SCYX Drug Manufacturers Specialty & Generic median
Market cap 30.64m 32.84m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack